Autolus Therapeutics (AUTL) EBT Margin (2017 - 2025)
Autolus Therapeutics posted quarterly EBT Margin of 376.78% for Q4 2025, up 8977495.0% year-on-year from N/an in Q4 2024, and down 1.61% on a QoQ basis from 370.79% in Q3 2025.
Autolus Therapeutics (AUTL) has 7 years of EBT Margin data on file, last reported at 376.78% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 8977495.0% year-over-year to 376.78%; the trailing twelve-month figure through Dec 2025 stood at 378.78% (up 178466.0% YoY), and the FY2025 full-year result was 378.78%, up 178657.0% from the prior year.
- EBT Margin for Q4 2025 stood at 376.78%, down from 370.79% in the prior quarter.
- Across five years, EBT Margin topped out at 2030.45% in Q4 2021 and bottomed at 16684745.76% in Q3 2021.
- The 5-year median for EBT Margin is 2623.09% (2021), against an average of 1294535.38%.
- The widest annual swing landed in 2021, when EBT Margin slumped 1667443069 bps; it then soared 8977495 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 2030.45% in 2021, then tumbled by 1200 bps to 22342.17% in 2022, then jumped by 49 bps to 11298.03% in 2023, then sank by 698 bps to 90151.72% in 2024, then jumped by 100 bps to 376.78% in 2025.
- The last three EBT Margin figures came in at 376.78% (Q4 2025), 370.79% (Q3 2025), and 227.12% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 41.95% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 23.05% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 18.99% |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | -376.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -376.78% |
| Sep 30, 2025 | -370.79% |
| Jun 30, 2025 | -227.12% |
| Mar 31, 2025 | -756.36% |
| Dec 31, 2024 | -90,151.72% |
| Mar 31, 2024 | -521.76% |
| Sep 30, 2023 | -11,298.03% |
| Mar 31, 2023 | -3,082.43% |
| Mar 31, 2022 | -22,342.17% |
| Dec 31, 2021 | 2,030.45% |
| Sep 30, 2021 | -16,684,745.76% |
| Jun 30, 2021 | -2,623.09% |
| Mar 31, 2021 | -14,494.42% |
| Dec 31, 2020 | -11,990.59% |
| Sep 30, 2020 | -10,315.07% |
| Jun 30, 2020 | -13,333.11% |
| Mar 31, 2020 | -9,931.66% |
| Dec 31, 2017 | -3,861.90% |